LifeStance Health Group Inc. Common Stock vs YieldMax NVDA Option Income Strategy ETF — how do they compare? LifeStance Health Group Inc. Common Stock trades at $12.42 (market cap $4.58B), while YieldMax NVDA Option Income Strategy ETF trades at $12.59 (market cap $1.45B). The key difference: LifeStance Health Group Inc. Common Stock is far larger — about 3.2× YieldMax NVDA Option Income Strategy ETF's market cap, and LifeStance Health Group Inc. Common Stock is trading nearer its 52-week high, YieldMax NVDA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold LifeStance Health Group Inc. Common Stock for 1 Days and YieldMax NVDA Option Income Strategy ETF for 43 Days on average.
| LFST | NVDY | |
|---|---|---|
Market Cap | $4.58B | $1.45B |
Volume | 2,356,698 | 1,943,739 |
Sector | Health | Income / Options Overlay |
52-Week High | $13.38 | $17.21 |
52-Week Low | $4.81 | $11.58 |
Typical Hold Time | 1 Days | 43 Days |
Enterprise Value | $4.82B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NVDY trades at $12.565, down 3.42% today amid bearish technical signals. The ETF shows consistent weekly dividend distributions but faces structural limitations on upside participation. Recent analyst coverage highlights declining volatility in underlying NVDA shares, reducing option income potential while NAV erosion remains a concern.
Outlook remains cautious as the fund's high distribution yield comes at the cost of long-term capital appreciation. Key risks include capped upside participation and dependency on NVDA volatility. Investors seeking pure NVDA exposure may find direct ownership more attractive for growth potential.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
LifeStance Health provides outpatient mental healthcare, including therapy, psychiatry, and medication management services.
Read more on LFST →NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →